Utility of PET/CT Imaging Performed Early After Surgical Resection in the Adjuvant Treatment Planning for Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 2, 2008, Pages 322-329

  Shintani, Stephanie A ^a   Foote, Robert L ^b   Lowe, Val J ^b   Brown, Paul D ^b   Garces, Yolanda I ^b   Kasperbauer, Jan L ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Mayo Clinic   (United States)

Author keywords

head neck cancer; PET CT; radiotherapy; surgery

Indexed keywords

BIOPSY; CELL CULTURE; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

HEAD AND NECK CANCER; SURGICAL RESECTION;

COMPUTERIZED TOMOGRAPHY;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; HEAD AND NECK CANCER; HOSPICE CARE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT ABANDONMENT; PATIENT CARE; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENT CANCER; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38149021493     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.038     Document Type: Article

References (20)

1. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
2. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
3. Di Martino E., Nowak B., Hassan H.A., et al. Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 126 (2000) 1457-1461
4. Ha P.K., Hdeib A., Goldenberg D., et al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132 (2006) 12-16
5. Kubota K. From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology. Ann Nucl Med 15 (2001) 471-486
6. Hannah A., Scott A.M., Tochon-Danguy H., et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 236 (2002) 208-217
7. Muylle K., Castaigne C., and Flamen P. 18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: Recent developments in head and neck cancer. Curr Opin Oncol 17 (2005) 249-253
8. Zimmer L.A., Branstetter B.F., Nayak J.V., et al. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope 115 (2005) 2029-2034
9. Lonneux M., Lawson G., Ide C., et al. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 110 (2000) 1493-1497
10. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [(18)F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
11. Lowe V.J., Boyd J.H., Dunphy F.R., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658
12. Goerres G.W., von Schulthess G.K., and Steinert H.C. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 45 Suppl. 1 (2004) 66S-71S
13. Branstetter B.F., Blodgett T.M., Zimmer L.A., et al. Head and neck malignancy: Is PET/CT more accurate than PET or CT alone?. Radiology 235 (2005) 580-586
14. Schoder H., Yeung H.W., Gonen M., et al. Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology 231 (2004) 65-72
15. Kapoor V., Fukui M.B., and McCook B.M. Role of 18FFDG PET/CT in the treatment of head and neck cancers: Principles, technique, normal distribution, and initial staging. AJR Am J Roentgenol 184 (2005) 579-587
16. Zimmer L.A., Snyderman C., Fukui M.B., et al. The use of combined PET/CT for localizing recurrent head and neck cancer: The Pittsburgh experience. Ear Nose Throat J 84 104 (2005) 108-110
17. Greene F.L., Page D.L., Fleming I.D., Fritz A.G., et al. AJCC cancer staging manual. 6th ed. (2002), Springer, New York
18. Forastiere A., Koch W., Trotti A., et al. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
19. Hollenbeak C.S., Lowe V.J., and Stack Jr. B.C. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer 92 (2001) 2341-2348
20. Koshy M., Paulino A.C., Howell R., et al. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 27 (2005) 494-502